Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of residual stenosis after percutaneous coronary intervention in patients with ischemic heart failure - A report from the CHART-2 study.
Hao K, Takahashi J, Sakata Y, Miyata S, Shiroto T, Nochioka K, Miura M, Oikawa T, Abe R, Sato M, Kasahara S, Aoyanagi H, Shimokawa H; CHART-2 Investigators. Hao K, et al. Among authors: aoyanagi h. Int J Cardiol. 2019 Mar 1;278:22-27. doi: 10.1016/j.ijcard.2018.10.062. Epub 2018 Oct 18. Int J Cardiol. 2019. PMID: 30366856
Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study.
Kasahara S, Sakata Y, Nochioka K, Yamauchi T, Onose T, Tsuji K, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Kasahara S, et al. Among authors: aoyanagi h. Heart Vessels. 2018 Sep;33(9):997-1007. doi: 10.1007/s00380-018-1150-4. Epub 2018 Mar 22. Heart Vessels. 2018. PMID: 29569034
The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study.
Kasahara S, Sakata Y, Nochioka K, Tay WT, Claggett BL, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Sugimura K, Teng TK, Miyata S, Shimokawa H. Kasahara S, et al. Among authors: aoyanagi h. Int J Cardiol. 2019 Jun 1;284:42-49. doi: 10.1016/j.ijcard.2018.10.076. Epub 2018 Oct 24. Int J Cardiol. 2019. PMID: 30413304
Gender differences in prognostic relevance of self-care behaviors on mortality and hospitalization in patients with heart failure - A report from the CHART-2 Study.
Abe R, Sakata Y, Nochioka K, Miura M, Oikawa T, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Abe R, et al. Among authors: aoyanagi h. J Cardiol. 2019 May;73(5):370-378. doi: 10.1016/j.jjcc.2018.11.006. Epub 2018 Dec 31. J Cardiol. 2019. PMID: 30606681 Free article.
Conversion formula from B-type natriuretic peptide to N-terminal proBNP values in patients with cardiovascular diseases.
Kasahara S, Sakata Y, Nochioka K, Miura M, Abe R, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Kasahara S, et al. Among authors: aoyanagi h. Int J Cardiol. 2019 Apr 1;280:184-189. doi: 10.1016/j.ijcard.2018.12.069. Epub 2019 Jan 7. Int J Cardiol. 2019. PMID: 30685104 Clinical Trial.
Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
Suzuki K, Oikawa T, Nochioka K, Miura M, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Takahashi J, Miyata S, Sakata Y, Shimokawa H. Suzuki K, et al. Among authors: aoyanagi h. Arterioscler Thromb Vasc Biol. 2019 May;39(5):934-944. doi: 10.1161/ATVBAHA.119.312336. Arterioscler Thromb Vasc Biol. 2019. PMID: 30866657 Free article.
Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
Oikawa T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Oikawa T, et al. Among authors: aoyanagi h. Int J Cardiol. 2019 Sep 1;290:106-112. doi: 10.1016/j.ijcard.2019.04.078. Epub 2019 Apr 26. Int J Cardiol. 2019. PMID: 31104823
Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study.
Oikawa T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Saga C, Ikeno Y, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Oikawa T, et al. Among authors: aoyanagi h. Int J Cardiol. 2019 Oct 15;293:17-24. doi: 10.1016/j.ijcard.2019.07.022. Epub 2019 Jul 12. Int J Cardiol. 2019. PMID: 31358306
Clinical benefits and risks of antithrombotic therapy in patients with atrial fibrillation with comorbidities - A report from the CHART-2 Study.
Shiroto T, Sakata Y, Nochioka K, Abe R, Kasahara S, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Hayashi H, Miura M, Takahashi J, Miyata S, Shimokawa H. Shiroto T, et al. Among authors: aoyanagi h. Int J Cardiol. 2020 Jan 15;299:160-168. doi: 10.1016/j.ijcard.2019.09.022. Epub 2019 Sep 11. Int J Cardiol. 2020. PMID: 31611087
Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases.
Takada T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Suzuki K, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Takada T, et al. Among authors: aoyanagi h. Int J Cardiol. 2020 May 15;307:87-93. doi: 10.1016/j.ijcard.2020.02.015. Epub 2020 Feb 6. Int J Cardiol. 2020. PMID: 32107021
16 results